Published in EMBO J on July 15, 1994
Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26
Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol (2001) 5.61
Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A (1995) 3.95
E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol (1995) 3.55
E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol (1996) 3.40
Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A (1995) 3.08
Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J (1996) 2.63
RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A (1997) 2.53
Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol (1996) 2.47
The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol (1996) 2.47
Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J (1996) 2.31
PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev (1997) 2.29
The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci U S A (1997) 2.24
Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10
An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol (1995) 2.08
Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol (1995) 1.87
Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci U S A (1995) 1.86
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J (1995) 1.67
Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell Biol (1996) 1.62
Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. EMBO J (1996) 1.61
Specific regulation of E2F family members by cyclin-dependent kinases. Mol Cell Biol (1997) 1.61
Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol (1999) 1.55
A genetic screen for modifiers of E2F in Drosophila melanogaster. Genetics (1999) 1.51
The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res (1996) 1.47
Gene expression changes in response to E2F1 activation. Nucleic Acids Res (2002) 1.44
Coupling of cell growth control and apoptosis functions of Id proteins. Mol Cell Biol (1998) 1.41
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol (1999) 1.29
Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A (1996) 1.29
Interplay between Arabidopsis activating factors E2Fb and E2Fa in cell cycle progression and development. Plant Physiol (2006) 1.15
E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol Cell Biol (1996) 1.09
E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol (1997) 1.09
Functional interaction between DP-1 and p53. Mol Cell Biol (1996) 1.06
Comparative analysis of E2F family member oncogenic activity. PLoS One (2007) 1.04
Inhibition of E2F-mediated transcription by p202. EMBO J (1996) 1.02
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci U S A (2003) 0.98
Regulation of endogenous E2F1 stability by the retinoblastoma family proteins. Proc Natl Acad Sci U S A (1999) 0.97
Small molecule regulators of Rb-E2F pathway as modulators of transcription. Biochim Biophys Acta (2010) 0.97
MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1. PLoS One (2014) 0.95
LIM only 4 is overexpressed in late stage pancreas cancer. Mol Cancer (2008) 0.94
Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein. J Virol (2000) 0.91
E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells. PLoS Pathog (2012) 0.89
Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients. Leukemia (2015) 0.87
Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells. Int J Radiat Oncol Biol Phys (2005) 0.85
Noise propagation in gene regulation networks involving interlinked positive and negative feedback loops. PLoS One (2012) 0.82
ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene. Biochem J (2006) 0.81
The adenovirus E4-6/7 protein directs nuclear localization of E2F-4 via an arginine-rich motif. J Virol (2005) 0.81
JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1. Cell Cycle (2011) 0.78
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (1992) 10.28
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (1993) 6.84
Identification of a cellular transcription factor involved in E1A trans-activation. Cell (1986) 6.36
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell (1992) 5.05
Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc Natl Acad Sci U S A (1987) 4.68
Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (1991) 4.62
Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev (1992) 4.56
The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell (1991) 4.42
The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell (1991) 4.24
Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14
Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol (1989) 4.10
Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell (1991) 3.98
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75
Cell cycle regulation of the human cdc2 gene. EMBO J (1992) 3.69
E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci U S A (1989) 3.67
A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell (1992) 3.64
Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol (1992) 3.58
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
Tumor suppressor genes. Cell (1991) 3.36
Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res (1989) 3.35
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature (1991) 3.20
A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J (1990) 3.07
The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol Cell Biol (1992) 3.06
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82
Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J (1993) 2.70
A new component of the transcription factor DRTF1/E2F. Nature (1993) 2.65
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1993) 2.61
Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells. Mol Cell Biol (1991) 2.42
The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol (1993) 2.41
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol (1990) 2.40
Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev (1991) 2.40
Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature (1992) 2.39
Association of cdk2 kinase with the transcription factor E2F during S phase. Science (1992) 2.37
Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol (1993) 2.34
Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex. EMBO J (1987) 2.30
The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol (1992) 2.21
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (1992) 1.93
Role of E2F transcription factor in E1A-mediated trans activation of cellular genes. J Virol (1991) 1.92
Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci U S A (1993) 1.84
Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci U S A (1993) 1.53
The adenovirus E4 gene, in addition to the E1A gene, is important for trans-activation of E2 transcription and for E2F activation. J Virol (1989) 1.50
Control of cellular and viral transcription during adenovirus infection. CRC Crit Rev Biochem (1986) 1.27
Multicomponent differentiation-regulated transcription factors in F9 embryonal carcinoma stem cells. Mol Cell Biol (1991) 0.99
Rb may act as a transcriptional co-activator in undifferentiated F9 cells. Oncogene (1993) 0.94
Cycles within cycles. Curr Biol (1991) 0.86
Transcriptional complexity. Curr Biol (1993) 0.81
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J Virol (2001) 2.55
SNX3 regulates endosomal function through its PX-domain-mediated interaction with PtdIns(3)P. Nat Cell Biol (2001) 2.33
A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature (1995) 2.07
Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells. J Cell Biol (1994) 2.04
Molecular cloning, characterization, subcellular localization and dynamics of p23, the mammalian KDEL receptor. J Cell Biol (1993) 1.98
The SXYQRL sequence in the cytoplasmic domain of TGN38 plays a major role in trans-Golgi network localization. J Biol Chem (1993) 1.93
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
The mammalian homolog of yeast Sec13p is enriched in the intermediate compartment and is essential for protein transport from the endoplasmic reticulum to the Golgi apparatus. Mol Cell Biol (1997) 1.77
Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem (1987) 1.75
The 17-residue transmembrane domain of beta-galactoside alpha 2,6-sialyltransferase is sufficient for Golgi retention. J Cell Biol (1992) 1.65
The recycling pathway of protein ERGIC-53 and dynamics of the ER-Golgi intermediate compartment. J Cell Sci (1998) 1.65
GS28, a 28-kilodalton Golgi SNARE that participates in ER-Golgi transport. Science (1996) 1.62
Localization and recycling of gp27 (hp24gamma3): complex formation with other p24 family members. Mol Biol Cell (1999) 1.60
Ykt6 forms a SNARE complex with syntaxin 5, GS28, and Bet1 and participates in a late stage in endoplasmic reticulum-Golgi transport. J Biol Chem (2001) 1.53
Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem Biophys Res Commun (1998) 1.50
Regulation of Golgi structure and function by ARF-like protein 1 (Arl1). J Cell Sci (2001) 1.47
Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome. Mol Biol Cell (1998) 1.43
Mammalian homologues of yeast sec31p. An ubiquitously expressed form is localized to endoplasmic reticulum (ER) exit sites and is essential for ER-Golgi transport. J Biol Chem (2000) 1.41
Gos1p, a Saccharomyces cerevisiae SNARE protein involved in Golgi transport. FEBS Lett (1998) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology (1995) 1.35
Role of p97 and syntaxin 5 in the assembly of transitional endoplasmic reticulum. Mol Biol Cell (2000) 1.34
The Phox homology (PX) domain, a new player in phosphoinositide signalling. Biochem J (2001) 1.31
A role for Tlg1p in the transport of proteins within the Golgi apparatus of Saccharomyces cerevisiae. Mol Biol Cell (1999) 1.31
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
Golgi retardation in Madin-Darby canine kidney and Chinese hamster ovary cells of a transmembrane chimera of two surface proteins. J Biol Chem (1994) 1.30
Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation. J Biol Chem (2001) 1.30
A membrane protein enriched in endoplasmic reticulum exit sites interacts with COPII. J Biol Chem (2001) 1.30
Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J Biol Chem (2000) 1.29
WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene (2010) 1.29
A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun (1996) 1.29
The reform of the rural cooperative medical system in the People's Republic of China: interim experience in 14 pilot counties. Soc Sci Med (1999) 1.28
Forward and retrograde trafficking in mitotic animal cells. ER-Golgi transport arrest restricts protein export from the ER into COPII-coated structures. J Cell Sci (1999) 1.26
A family of mammalian proteins homologous to yeast Sec24p. Biochem Biophys Res Commun (1999) 1.26
Inhibition by brefeldin A of protein secretion from the apical cell surface of Madin-Darby canine kidney cells. J Biol Chem (1991) 1.25
A 29-kilodalton Golgi soluble N-ethylmaleimide-sensitive factor attachment protein receptor (Vti1-rp2) implicated in protein trafficking in the secretory pathway. J Biol Chem (1998) 1.24
Acute torsion of the gall bladder in the aged: a re-emphasis on clinical diagnosis. Aust N Z J Surg (1982) 1.21
Segregation of ERGIC53 and the mammalian KDEL receptor upon exit from the 15 degrees C compartment. Eur J Cell Biol (1995) 1.19
The transmembrane domain of N-glucosaminyltransferase I contains a Golgi retention signal. J Biol Chem (1992) 1.16
GS32, a novel Golgi SNARE of 32 kDa, interacts preferentially with syntaxin 6. Mol Biol Cell (1999) 1.16
Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells. Infect Immun (2006) 1.16
Syntaxin 7, a novel syntaxin member associated with the early endosomal compartment. J Biol Chem (1998) 1.15
Molecular cloning and localization of human syntaxin 16, a member of the syntaxin family of SNARE proteins. Biochem Biophys Res Commun (1998) 1.13
Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART). J Thromb Haemost (2013) 1.13
Selective inhibition of protein targeting to the apical domain of MDCK cells by brefeldin A. J Cell Biol (1992) 1.12
The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochim Biophys Acta (1984) 1.12
Endofin, an endosomal FYVE domain protein. J Biol Chem (2001) 1.11
Retinoblastoma-binding protein 2 (Rbp2) potentiates nuclear hormone receptor-mediated transcription. J Biol Chem (2001) 1.11
Apical cell surface expression of rat dipeptidyl peptidase IV in transfected Madin-Darby canine kidney cells. J Biol Chem (1991) 1.11
Monoclonal antibody HFD9 identifies a novel 28 kDa integral membrane protein on the cis-Golgi. J Cell Sci (1995) 1.10
Evidence for prebudding arrest of ER export in animal cell mitosis and its role in generating Golgi partitioning intermediates. Traffic (2001) 1.10
Morphological and functional association of Sec22b/ERS-24 with the pre-Golgi intermediate compartment. Mol Biol Cell (1999) 1.10
A novel synaptobrevin/VAMP homologous protein (VAMP5) is increased during in vitro myogenesis and present in the plasma membrane. Mol Biol Cell (1998) 1.09
Negative findings at appendectomy. Am J Surg (1984) 1.08
Syntaxin 12, a member of the syntaxin family localized to the endosome. J Biol Chem (1998) 1.08
Preferential association of syntaxin 8 with the early endosome. J Cell Sci (2000) 1.06
A SNARE involved in protein transport through the Golgi apparatus. Nature (1997) 1.06
GS15, a 15-kilodalton Golgi soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) homologous to rbet1. J Biol Chem (1997) 1.06
Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ (2011) 1.06
The mammalian ARF-like protein 1 (Arl1) is associated with the Golgi complex. J Cell Sci (1996) 1.06
ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. FEBS Lett (1999) 1.04
Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet (2001) 1.02
Retention of a type II surface membrane protein in the endoplasmic reticulum by the Lys-Asp-Glu-Leu sequence. J Biol Chem (1992) 1.02
N-Ethylmaleimide-sensitive factor (NSF) and alpha-soluble NSF attachment proteins (SNAP) mediate dissociation of GS28-syntaxin 5 Golgi SNAP receptors (SNARE) complex. J Biol Chem (1997) 1.01
Sodium ramping reduces hypotension and symptoms during haemodialysis. Hong Kong Med J (2006) 1.00
Early events in spontaneous neutrophil apoptosis. Biochem Soc Trans (2004) 1.00
Randomized, prospective trial of topical hydrogen peroxide in appendectomy wound infection. High risk factors. Am J Surg (1981) 0.99
Conventional vs. triple rubber band ligation for hemorrhoids. A prospective, randomized trial. Dis Colon Rectum (1986) 0.98
Programmable motion and patterning of molecules on solid surfaces. Proc Natl Acad Sci U S A (2004) 0.97
Rubber band ligation of three primary hemorrhoids in a single session. A safe and effective procedure. Dis Colon Rectum (1982) 0.97
Otorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma. Am J Otolaryngol (1999) 0.97
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis. Mult Scler (2008) 0.97
Preoperative and intraoperative localisation of gastrointestinal bleeding of obscure origin. Gut (1987) 0.97
Syntaxin 10: a member of the syntaxin family localized to the trans-Golgi network. Biochem Biophys Res Commun (1998) 0.96
Differential response of resident proteins and cycling proteins of the Golgi to brefeldin A. Eur J Cell Biol (1995) 0.96
Involvement of both vectorial and transcytotic pathways in the preferential apical cell surface localization of rat dipeptidyl peptidase IV in transfected LLC-PK1 cells. J Biol Chem (1991) 0.95
An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre. J Neurol (2014) 0.95
Syntaxin 11: a member of the syntaxin family without a carboxyl terminal transmembrane domain. Biochem Biophys Res Commun (1998) 0.94
Prophylaxis of post-appendicectomy sepsis by metronidazole and ampicillin: a randomized, prospective and double-blind trial. Br J Surg (1983) 0.93
Childhood-onset schizophrenia: an NIMH study in progress. Schizophr Bull (1994) 0.92
Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes. Glycoconj J (1997) 0.92